نتائج البحث 41-50 من 11158 لعملية البحث عن Vaginal%2Bcancer
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients ... The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and ...
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers are HER2-positive, which are ...
Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of-care primary surgical ...
... vaginal recurrence among patients with surgical stage I intermediate-risk endometrial cancer. Eligible patients presenting with apparent uterine confined ...
... cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving ...
A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer ... vaginal fluid and/or plasma. Bladder Bank ...
... tumors or lymphoma. A Study of Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.